GlassScriptPhysician profile
David Andrew Lindenberg
NPI 1881909141
$7,433.70
in general payments reported to CMS, 2019-2025
41 companies · $1,864 in 2025
The $1,864 reported for 2025 was more than what 85% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $555 · 2020: $557 · 2021: $1,601 · 2022: $1,210 · 2023: $768 · 2024: $879 · 2025: $1,864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,716 · Travel and Lodging: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,716.29 |
| Travel and Lodging | $794.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,491.41 | 2019-2025 | General - Therapies, Wavewriter Alpha Prime 16, General - Pain Management |
| Painteq LLC | $603.55 | 2021-2023 | Painteq |
| Abbvie INC. | $405.38 | 2021-2025 | |
| Si-Bone, INC. | $357.71 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $244.89 | 2021-2025 | Relistor |
| Biohaven Pharmaceuticals, INC. | $238.46 | 2021 | |
| Collegium Pharmaceutical, INC. | $193.95 | 2019-2025 | Belbuca |
| Medtronic, INC. | $165.52 | 2021-2022 | |
| Allergan, INC. | $164.54 | 2019-2022 | |
| Nevro Corp. | $158.17 | 2019-2024 | Senza |
| Amgen INC. | $132.99 | 2019 | |
| Scilex Pharmaceuticals INC. | $130.48 | 2019-2025 | Ztlido |
| Pfizer INC. | $116.01 | 2019-2024 | |
| Biotronik Nro, INC. | $106.26 | 2024 | Prospera |
| Abbott Laboratories | $86.08 | 2021-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lindenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.